Gilead produces mixed COVID-19 trial results – investors now look to Mesoblast.

Biotechs universally share one mission. The industry aims to prevent or cure diseases to sustain a higher life expectancy. If a biotech successfully achieves its mission, humankind, the patients suffering, and investors all experience euphoria. However, if a biotech fails to develop a viable drug then the nightmarish scenario of people suffering continues. It seems […]

How Gilead drove a US rally based on optimism.

The Dow Jones rallied upwards of 700 points on Friday as Gilead’s (NASDAQ:GILD) “Wonder Drug”  has shown promising results according to a Chicago University source. The video of Infectious Disease Professor Kathleen Mullane, goes into some detail over the success of Remdesivir in recent trials with patients reporting fast recoveries from COVID-19. Now if you […]

Gilead Sciences wonder drug showing promise in the COVID-19 battle

Gilead Sciences (NASDAQ:GILD) has made promising progress in the treatment of COVID-19 with their drug Remdesivir. The US Bio-tech giant conducted a trial with 53 patients with COVID-19 in the US, Canada and Europe. All 53 patients were considered to have severe complications due to the virus, all needing respiratory support. “The majority of patients […]